As part of the Lancet Group’s commitment to increasing gender equity, diversity, and inclusion in research and publishing, all of the publishing group’s 18 medical journals have adopted a new Diversity Pledge and No All-Male Panel Policy. At the same time, the Group reports progress on improving the representation ofRead
Both aspirin and omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA), reduced the number of precancerous colon polyps in patients found to be at high risk of developing bowel cancer, according to new research published in the journal Lancet. This study, called the seAFOod Trial, is the result of a multidisciplinaryRead
Diabetes remission, without drugs, is possible, according to this just published Lancet study. Researchers found that nearly half of of the study subjects achieved and maintained diabetes remission at one year without anti-diabetic medications. Subjects with diabetes for as long as 6 years were able to reverse diabetes following anRead
The long awaited PURE study is out and the results will put the supporters of diets low in all types of fats into a carbohydrate-fueled tailspin. According to the large cohort Prospective Urban Rural Epidemiology (PURE) study, higher fat diets that include both saturated and unsaturated fats are associated withRead
The fountain of youth for heart health isn’t a fountain at all. It’s deep within the Bolivian Amazon. A new study in Lancet shows the Tsimane people – a forager-horticulturalist population – are five times less likely to suffer from coronary atherosclerosis than Americans. The study presented at the AmericanRead
Nearly three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care, according to three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology. Lead author Professor Michael Sharpe from the University of Oxford in the UK, says “The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer.” By M Sharpe, et al., published in the Lancet and Lancet Oncology, Aug. 2014.